Greater Baltimore Medical Center
Clinical research site in Towson, Maryland · 6565 N CHARLES ST, SUITE 203, TOWSON, MD 21204-6800 · (443) 849-3760
As of September 2026, 3 paid clinical trials are recruiting at Greater Baltimore Medical Center in Towson, Maryland. Active studies at this site cover conditions such as Follicular Lymphoma, Ovarian Cancer and Triple Negative Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Greater Baltimore Medical Center (3)
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Get new-trial alerts for Greater Baltimore Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Towson, MD. Unsubscribe anytime.
More research sites in Towson
- UM Saint Joseph Medical Center (8 trials)
- Chesapeake Urology Research Associates (4 trials)
- University of Maryland St. Joseph Medical Center (4 trials)
- Retina Specialists (3 trials)
- Centers for Advanced ENT Care (2 trials)
- Chesapeake Urology (2 trials)
- Acromion LLC (1 trial)
- Chesapeake Urology Associates (1 trial)
- Continental Clinical Solutions (1 trial)
- Massive Bio SYNERGY-AI site (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Towson, MD · Maryland clinical trials